These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
70 related items for PubMed ID: 1623931
1. Low-molecular weight B cell growth factor (BCGF-12KD) as an autocrine growth factor in B cell chronic lymphocytic leukemia. Fournier S, Jackson J, Kumar A, King T, Sharma S, Biron G, Rubio M, Delespesse G, Sarfati M. Eur J Immunol; 1992 Jul; 22(7):1927-30. PubMed ID: 1623931 [Abstract] [Full Text] [Related]
2. Human BCGF-12kD functions as an autocrine growth factor in transformed B cells. Kumar A, Vasquez A, Maizel AL, Sharma S. Eur Cytokine Netw; 1990 Jul; 1(2):109-13. PubMed ID: 1966378 [Abstract] [Full Text] [Related]
3. Detection and characterization of human high molecular weight B cell growth factor receptors on leukemic B cells in chronic lymphocytic leukemia. Uckun FM, Fauci AS, Chandan-Langlie M, Myers DE, Ambrus JL. J Clin Invest; 1989 Nov; 84(5):1595-608. PubMed ID: 2681271 [Abstract] [Full Text] [Related]
4. A case of human B cell leukemia that implicates an autocrine mechanism in the abnormal growth of Leu 1 B cells. Kawamura N, Muraguchi A, Hori A, Horii Y, Mutsuura S, Hardy RR, Kikutani H, Kishimoto T. J Clin Invest; 1986 Nov; 78(5):1331-8. PubMed ID: 3490495 [Abstract] [Full Text] [Related]
5. Recombinant human interleukin 5 is an eosinophil differentiation factor but has no activity in standard human B cell growth factor assays. Clutterbuck E, Shields JG, Gordon J, Smith SH, Boyd A, Callard RE, Campbell HD, Young IG, Sanderson CJ. Eur J Immunol; 1987 Dec; 17(12):1743-50. PubMed ID: 3500861 [Abstract] [Full Text] [Related]
6. Identification and characterization of a B cell growth inhibitory factor (BIF) on BCGF-dependent B cell proliferation. Kawano M, Iwato K, Kuramoto A. J Immunol; 1985 Jan; 134(1):375-81. PubMed ID: 3871108 [Abstract] [Full Text] [Related]
7. Synergy of B cell growth factor and interleukin 2 in the proliferation of activated human B cells. Romagnani S, Giudizi GM, Maggi E, Almerigogna F, Biagiotti R, Del Prete G, Mazzetti M, Alessi A, Vercelli D, Ricci M. Eur J Immunol; 1985 Dec; 15(12):1158-64. PubMed ID: 3936718 [Abstract] [Full Text] [Related]
8. Leukemic cells from progressive B-CLL respond strongly to growth stimulation in vitro. Aguilar-Santelises M, Mellstedt H, Jondal M. Leukemia; 1994 Jul; 8(7):1146-52. PubMed ID: 8035606 [Abstract] [Full Text] [Related]
9. In vitro effects of B cell growth and maturation factor on B-CLL lymphocytes. Karray S, Emilie D, Galanaud P. Nouv Rev Fr Hematol (1978); 1988 Jul; 30(5-6):275-8. PubMed ID: 3065728 [Abstract] [Full Text] [Related]
10. Characterization of B cell growth in systemic lupus erythematosus. Effects of recombinant 12-kDa B cell growth factor, interleukin 4 and transforming growth factor-beta. Flescher E, Fossum D, Ballester A, Maizel A, Sharma S, Talal N. Eur J Immunol; 1990 Nov; 20(11):2425-30. PubMed ID: 2253682 [Abstract] [Full Text] [Related]
11. Cross-linking of membrane IgM on B CLL cells: dissociation between intracellular free Ca2+ mobilization and cell proliferation. Hivroz C, Grillot-Courvalin C, Labaume S, Miglierina R, Brouet JC. Eur J Immunol; 1988 Nov; 18(11):1811-7. PubMed ID: 3144454 [Abstract] [Full Text] [Related]
12. C3b receptors mediate the growth factor-induced proliferation of malignant B-chronic lymphocytic leukemia lymphocytes. Caligaris-Cappio F, Schena M, Bergui L, Tesio L, Riva M, Rege-Cambrin G, Funaro A, Malavasi F. Leukemia; 1987 Nov; 1(11):746-52. PubMed ID: 2960860 [Abstract] [Full Text] [Related]
13. Heterogeneity of responsiveness of chronic lymphocytic leukemic B cells to B cell growth factor or interleukin 2. Hivroz C, Grillot-Courvalin C, Brouet JC, Seligmann M. Eur J Immunol; 1986 Aug; 16(8):1001-4. PubMed ID: 3488907 [Abstract] [Full Text] [Related]
14. Modulation of IL-2-induced human B cell proliferation in the presence of human 50-kDa B cell growth factor and IL-4. Vazquez A, Mills S, Maizel A. J Immunol; 1989 Jan 01; 142(1):94-9. PubMed ID: 2783328 [Abstract] [Full Text] [Related]
15. Stimulation of B-chronic lymphocytic leukemia cells by murine fibroblasts, IL-4, anti-CD40 antibodies, and the soluble CD40 ligand. Buske C, Gogowski G, Schreiber K, Rave-Fränk M, Hiddemann W, Wörmann B. Exp Hematol; 1997 Apr 01; 25(4):329-37. PubMed ID: 9131008 [Abstract] [Full Text] [Related]
16. B cell growth and differentiation factors interact with receptors distinct from the interleukin 2 receptor. Kehrl JH, Grove JH, Goldsmith PK, Fauci AS. Eur J Immunol; 1986 Jul 01; 16(7):761-6. PubMed ID: 3013645 [Abstract] [Full Text] [Related]
17. Analysis of the role of interferon-gamma, interleukin 2 and a third factor distinct from interferon-gamma and interleukin 2 in human B cell proliferation. Evidence that they act at different times after B cell activation. Romagnani S, Giudizi GM, Almerigogna F, Biagiotti R, Alessi A, Mingari C, Liang CM, Moretta L, Ricci M. Eur J Immunol; 1986 Jun 01; 16(6):623-9. PubMed ID: 3087756 [Abstract] [Full Text] [Related]
18. Immunotoxin-mediated inhibition of chronic lymphocytic leukemia cell proliferation in humans. Siena S, Bregni M, Formosa A, Brando B, Marenco P, Lappi DA, Bonadonna G, Gianni AM. Cancer Res; 1989 Jun 15; 49(12):3328-32. PubMed ID: 2785850 [Abstract] [Full Text] [Related]
19. Functional studies examining the subpopulation of human B lymphocytes responding to high molecular weight B cell growth factor. Ambrus JL, Chesky L, Stephany D, McFarland P, Mostowski H, Fauci AS. J Immunol; 1990 Dec 15; 145(12):3949-55. PubMed ID: 2258603 [Abstract] [Full Text] [Related]
20. Large granular lymphocytes from B-chronic lymphocytic leukemia patients inhibit normal B cell proliferation. Perri RT, Kay NE. Am J Hematol; 1989 Jul 15; 31(3):166-72. PubMed ID: 2500849 [Abstract] [Full Text] [Related] Page: [Next] [New Search]